Valuation GSK plc Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 15:45:29 2026-10-02 EDT			5-day change	1st Jan Change
20.72 ^EUR	-2.03%		-3.40%	-1.33%

10-02	Major drugmakers turn to China for licensing deals	RE
10-01	GSK plc : JP Morgan reiterates its Sell rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	71,305	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	-2.59%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	92,547	89,822	87,001
Change	-	-24.65%	-1.89%	-8.24%	28.83%	5.58%	-2.94%	-3.14%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	13.8x	11.4x	10.5x
PBR	5.34x	5.47x	4.4x	4.02x	4.51x	4.4x	3.88x	3.43x
PEG	-	0x	-0.2x	-0.4x	0x	-1.59x	0.5x	1.28x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.1x	2.01x	1.95x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.73x	2.53x	2.38x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.07x	7.32x	6.84x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	8.98x	8.13x	7.55x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.5x	15.7x	13x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.05%	6.37%	7.67%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7494	0.7843
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.91%	4.21%	4.41%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.289	1.566	1.694
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	54%	47.9%	46.3%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,920	35,498	36,615
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,473	12,275	12,711
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,310	11,046	11,531
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,191	6,209	6,755
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	21,242	18,517	15,696
Reference price ²	20.08	14.38	14.50	13.46	18.24	17.80	17.80	17.80
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%